General Information of the Compound
| Compound ID |
CP0272023
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
3-[[4-(2-methoxyphenyl)piperazin-1-yl]methyl]-8-(4-nitrophenyl)sulfonyl-1,4-dioxa-8-azaspiro[4.5]decane
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C25H32N4O7S
|
||||||||||||||||||
| Molecular Weight |
532.619
|
||||||||||||||||||
| Canonical SMILES |
COc1ccccc1N1CCN(CC2COC3(CCN(CC3)S(=O)(=O)c3ccc(cc3)[N+]([O-])=O)O2)CC1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C25H32N4O7S/c1-34-24-5-3-2-4-23(24)27-16-14-26(15-17-27)18-21-19-35-25(36-21)10-12-28(13-11-25)37(32,33)22-8-6-20(7-9-22)29(30)31/h2-9,21H,10-19H2,1H3
Show/Hide
|
||||||||||||||||||
| InChIKey |
KTBIQCRMHWZGGG-UHFFFAOYSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT00819, 5-hydroxytryptamine receptor 1A
Protein ID: PT01089, Alpha-1A adrenergic receptor
Protein ID: PT01007, Alpha-1B adrenergic receptor
Protein ID: PT01004, Alpha-1D adrenergic receptor